APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pneumococcal Vaccine Polyvalent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pneumococcal Vaccine Polyvalent Industry Growth and Trends Forecast to 2032

20 December 202572 pages

Choose your research edition.

Industry ResearchPneumococcal Vaccine Polyvalent Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumococcal Vaccine Polyvalent Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Pneumococcal Vaccine Polyvalent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumococcal Vaccine Polyvalent Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumococcal Vaccine Polyvalent Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Pneumococcal Vaccine Polyvalent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pneumococcal Vaccine Polyvalent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pneumococcal Vaccine Polyvalent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pneumococcal Vaccine Polyvalent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pneumococcal Vaccine Polyvalent include Merck & Co. and Pfizer among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pneumococcal Vaccine Polyvalent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pneumococcal Vaccine Polyvalent market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pneumococcal Vaccine Polyvalent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pneumococcal Vaccine Polyvalent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pneumococcal Vaccine Polyvalent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pneumococcal Vaccine Polyvalent Market by Company

Merck & Co.

Pfizer

Pneumococcal Vaccine Polyvalent Segment by Type

Prevnar 13

Pneumovax23

Pneumococcal Vaccine Polyvalent Segment by Application

65 Years and Older

19 To 64 Years Old

18 Years and Younger

Pneumococcal Vaccine Polyvalent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine Polyvalent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine Polyvalent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine Polyvalent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pneumococcal Vaccine Polyvalent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pneumococcal Vaccine Polyvalent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Prevnar 13 Table 2. Major Company of Pneumovax23 Table 3. Global Pneumococcal Vaccine Polyvalent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (W Units) Table 5. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type (2021-2026) Table 8. Global Pneumococcal Vaccine Polyvalent Price by Type (2021-2026) & (US$/Unit) Table 9. Global Pneumococcal Vaccine Polyvalent Sales by Type (2027-2032) & (W Units) Table 10. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pneumococcal Vaccine Polyvalent Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type (2027-2032) Table 13. Global Pneumococcal Vaccine Polyvalent Price by Type (2027-2032) & (US$/Unit) Table 14. North America Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (W Units) Table 15. North America Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (W Units) Table 17. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (W Units) Table 21. Latin America Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Type (2021-2026) & (US$ Million) Table 24. Pneumococcal Vaccine Polyvalent Industry Trends Table 25. Pneumococcal Vaccine Polyvalent Industry Drivers Table 26. Pneumococcal Vaccine Polyvalent Industry Opportunities and Challenges Table 27. Pneumococcal Vaccine Polyvalent Industry Restraints Table 28. Global Pneumococcal Vaccine Polyvalent Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Company (2021-2026) Table 30. Global Pneumococcal Vaccine Polyvalent Sales by Company (2021-2026) & (W Units) Table 31. Global Pneumococcal Vaccine Polyvalent Sales Share by Company (2021-2026) Table 32. Global Pneumococcal Vaccine Polyvalent Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Pneumococcal Vaccine Polyvalent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pneumococcal Vaccine Polyvalent Major Company Production Sites and Headquarters Table 35. Global Pneumococcal Vaccine Polyvalent Company, Product Type & Application Table 36. Global Pneumococcal Vaccine Polyvalent Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pneumococcal Vaccine Polyvalent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pneumococcal Vaccine Polyvalent Sales by Region (2021-2026) & (W Units) Table 41. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pneumococcal Vaccine Polyvalent Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Region (2021-2026) Table 44. Global Pneumococcal Vaccine Polyvalent Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Pneumococcal Vaccine Polyvalent Sales by Region (2027-2032) & (W Units) Table 46. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pneumococcal Vaccine Polyvalent Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Region (2027-2032) Table 49. Global Pneumococcal Vaccine Polyvalent Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Pneumococcal Vaccine Polyvalent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (W Units) Table 52. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application (2021-2026) Table 55. Global Pneumococcal Vaccine Polyvalent Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pneumococcal Vaccine Polyvalent Sales by Application (2027-2032) & (W Units) Table 57. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pneumococcal Vaccine Polyvalent Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application (2027-2032) Table 60. Global Pneumococcal Vaccine Polyvalent Price by Application (2027-2032) & (US$/Unit) Table 61. North America Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (W Units) Table 62. North America Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (W Units) Table 64. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (W Units) Table 68. Latin America Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Application (2021-2026) & (US$ Million) Table 71. Merck & Co. Company Information Table 72. Merck & Co. Business Overview Table 73. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Merck & Co. Pneumococcal Vaccine Polyvalent Product Portfolio Table 75. Merck & Co. Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Pneumococcal Vaccine Polyvalent Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pfizer Pneumococcal Vaccine Polyvalent Product Portfolio Table 80. Pfizer Recent Development Table 81. North America Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 82. North America Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (W Units) Table 83. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2021-2026) Table 84. North America Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032) & (W Units) Table 85. North America Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Country (2027-2032) Table 86. North America Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Pneumococcal Vaccine Polyvalent Market Share by Country (2021-2026) Table 89. North America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Pneumococcal Vaccine Polyvalent Market Share Forecast by Country (2027-2032) Table 91. Europe Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 92. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (W Units) Table 93. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2021-2026) Table 94. Europe Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032) & (W Units) Table 95. Europe Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Pneumococcal Vaccine Polyvalent Market Share by Country (2021-2026) Table 99. Europe Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Pneumococcal Vaccine Polyvalent Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (W Units) Table 103. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032) & (W Units) Table 105. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Share by Country (2021-2026) Table 109. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Share Forecast by Country (2027-2032) Table 111. Latin America Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 112. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (W Units) Table 113. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2021-2026) Table 114. Latin America Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032) & (W Units) Table 115. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Pneumococcal Vaccine Polyvalent Market Share by Country (2021-2026) Table 119. Latin America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Pneumococcal Vaccine Polyvalent Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026) & (W Units) Table 123. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032) & (W Units) Table 125. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Share by Country (2021-2026) Table 129. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Pneumococcal Vaccine Polyvalent Distributors List Table 134. Pneumococcal Vaccine Polyvalent Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Pneumococcal Vaccine Polyvalent Image Figure 2. Global Pneumococcal Vaccine Polyvalent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumococcal Vaccine Polyvalent Market Size (2021-2032) & (US$ Million) Figure 4. Global Pneumococcal Vaccine Polyvalent Sales (2021-2032) & (W Units) Figure 5. Prevnar 13 Image Figure 6. Global Prevnar 13 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Pneumovax23 Image Figure 8. Global Pneumovax23 Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Pneumococcal Vaccine Polyvalent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pneumococcal Vaccine Polyvalent Market Share by Type 2025 VS 2032 Figure 11. North America Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type in 2025 Figure 12. North America Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type in 2025 Figure 13. Europe Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pneumococcal Vaccine Polyvalent Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 65 Years and Older Image Figure 24. Global 65 Years and Older Sales YoY Growth (2021-2032) & (W Units) Figure 25. 19 To 64 Years Old Image Figure 26. Global 19 To 64 Years Old Sales YoY Growth (2021-2032) & (W Units) Figure 27. 18 Years and Younger Image Figure 28. Global 18 Years and Younger Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Pneumococcal Vaccine Polyvalent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pneumococcal Vaccine Polyvalent Market Share by Application 2025 VS 2032 Figure 31. North America Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application in 2025 Figure 32. North America Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application in 2025 Figure 33. Europe Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share in Value by Application in 2025 Figure 41. North America Pneumococcal Vaccine Polyvalent Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Pneumococcal Vaccine Polyvalent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pneumococcal Vaccine Polyvalent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pneumococcal Vaccine Polyvalent Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pneumococcal Vaccine Polyvalent Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Pneumococcal Vaccine Polyvalent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pneumococcal Vaccine Polyvalent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pneumococcal Vaccine Polyvalent Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pneumococcal Vaccine Polyvalent Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Pneumococcal Vaccine Polyvalent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pneumococcal Vaccine Polyvalent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pneumococcal Vaccine Polyvalent Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pneumococcal Vaccine Polyvalent Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pneumococcal Vaccine Polyvalent Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pneumococcal Vaccine Polyvalent Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Prevnar 13
  • Pneumovax23
Applications
  • 65 Years and Older
  • 19 To 64 Years Old
  • 18 Years and Younger
Companies covered
  • Merck & Co.
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pneumococcal Vaccine Polyvalent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pneumococcal Vaccine Polyvalent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pneumococcal Vaccine Polyvalent Market by Type
  6. 1.3.1 Prevnar 13
  7. 1.3.2 Pneumovax23
  8. 1.4 Global Pneumococcal Vaccine Polyvalent Market Size by Type
  9. 1.4.1 Global Pneumococcal Vaccine Polyvalent Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pneumococcal Vaccine Polyvalent Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pneumococcal Vaccine Polyvalent Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pneumococcal Vaccine Polyvalent Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pneumococcal Vaccine Polyvalent Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pneumococcal Vaccine Polyvalent Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pneumococcal Vaccine Polyvalent Industry Trends
  2. 2.2 Pneumococcal Vaccine Polyvalent Industry Drivers
  3. 2.3 Pneumococcal Vaccine Polyvalent Industry Opportunities and Challenges
  4. 2.4 Pneumococcal Vaccine Polyvalent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pneumococcal Vaccine Polyvalent Revenue (2021-2026)
  2. 3.2 Global Top Players by Pneumococcal Vaccine Polyvalent Sales (2021-2026)
  3. 3.3 Global Top Players by Pneumococcal Vaccine Polyvalent Price (2021-2026)
  4. 3.4 Global Pneumococcal Vaccine Polyvalent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pneumococcal Vaccine Polyvalent Major Company Production Sites & Headquarters
  6. 3.6 Global Pneumococcal Vaccine Polyvalent Company, Product Type & Application
  7. 3.7 Global Pneumococcal Vaccine Polyvalent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pneumococcal Vaccine Polyvalent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pneumococcal Vaccine Polyvalent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pneumococcal Vaccine Polyvalent Tier 1, Tier 2, and Tier 3
4 Pneumococcal Vaccine Polyvalent Regional Status and Outlook
  1. 4.1 Global Pneumococcal Vaccine Polyvalent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pneumococcal Vaccine Polyvalent Historic Market Size by Region
  3. 4.2.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pneumococcal Vaccine Polyvalent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pneumococcal Vaccine Polyvalent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pneumococcal Vaccine Polyvalent Forecasted Market Size by Region
  7. 4.3.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pneumococcal Vaccine Polyvalent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pneumococcal Vaccine Polyvalent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pneumococcal Vaccine Polyvalent by Application
  1. 5.1 Pneumococcal Vaccine Polyvalent Market by Application
  2. 5.1.1 65 Years and Older
  3. 5.1.2 19 To 64 Years Old
  4. 5.1.3 18 Years and Younger
  5. 5.2 Global Pneumococcal Vaccine Polyvalent Market Size by Application
  6. 5.2.1 Global Pneumococcal Vaccine Polyvalent Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pneumococcal Vaccine Polyvalent Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pneumococcal Vaccine Polyvalent Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pneumococcal Vaccine Polyvalent Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pneumococcal Vaccine Polyvalent Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pneumococcal Vaccine Polyvalent Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co.
  2. 6.1.1 Merck & Co. Company Information
  3. 6.1.2 Merck & Co. Business Overview
  4. 6.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Product Portfolio
  6. 6.1.5 Merck & Co. Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Pneumococcal Vaccine Polyvalent Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
7 North America by Country
  1. 7.1 North America Pneumococcal Vaccine Polyvalent Sales by Country
  2. 7.1.1 North America Pneumococcal Vaccine Polyvalent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026)
  4. 7.1.3 North America Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pneumococcal Vaccine Polyvalent Market Size by Country
  6. 7.2.1 North America Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026)
  8. 7.2.3 North America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pneumococcal Vaccine Polyvalent Sales by Country
  2. 8.1.1 Europe Pneumococcal Vaccine Polyvalent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026)
  4. 8.1.3 Europe Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pneumococcal Vaccine Polyvalent Market Size by Country
  6. 8.2.1 Europe Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Country
  2. 9.1.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Country
  6. 9.2.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pneumococcal Vaccine Polyvalent Sales by Country
  2. 10.1.1 South America Pneumococcal Vaccine Polyvalent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026)
  4. 10.1.3 South America Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pneumococcal Vaccine Polyvalent Market Size by Country
  6. 10.2.1 South America Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026)
  8. 10.2.3 South America Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country
  2. 11.1.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country
  6. 11.2.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pneumococcal Vaccine Polyvalent Value Chain Analysis
  2. 12.1.1 Pneumococcal Vaccine Polyvalent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pneumococcal Vaccine Polyvalent Production Mode & Process
  7. 12.2 Pneumococcal Vaccine Polyvalent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pneumococcal Vaccine Polyvalent Distributors
  10. 12.2.3 Pneumococcal Vaccine Polyvalent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst